The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2025 | Addressing unwarranted variation to improve healthcare quality and equity in lung cancer
David Baldwin, MD, FRCP, Nottingham City Hospital, Nottingham, UK, emphasizes the importance of identifying unwarranted variation in healthcare systems, which is variation that cannot be explained by natural factors such as population differences or individual variability. Prof. Baldwin highlights that addressing this variation is crucial for improving service quality and outcomes, as well as ensuring fairness and equity in the system, making it a morally and ethically justifiable goal. This interview took place at the BTOG 2025 congress in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
